← All stocks

MapLight Therapeutics, Inc.

MPLT No buying or selling

CIK 0001770069 #3078 in the set updated 17 Sep 2026

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$0.00

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 0 sales

Net

$0.00

$0.00 against sales at will

By person

16 insiders · 0 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Catalyst4, Inc. entity

10% owner

—

25,306,689

59.63%

$287.99M

—

Novo Holdings A/S entity

10% owner

—

3,686,622

8.69%

$41.95M

—

Kroeger Christopher A.

Chief Executive Officer

—

1,269,600

2.99%

$14.45M

−20.7%

Setia Vishwas

Chief Financial Officer

—

356,256

0.8395%

$4.05M

−5.7%

Malenka Robert C.

Director

—

348,138

0.8204%

$3.96M

−11.4%

Foff Erin Pennock

Chief Medical Officer

—

312,261

0.7358%

$3.55M

−19.3%

Lillie James Woodruff

Chief Scientific Officer

—

210,110

0.4951%

$2.39M

−31.0%

Kreitzer Anatol

Chief Discovery Officer

—

180,926

0.4263%

$2.06M

−30.4%

Hanson Kristopher

General Counsel

—

153,553

0.3618%

$1.75M

−16.2%

GILLIS JONATHAN

CAO and Interim CFO

—

152,482

0.3593%

$1.74M

−36.5%

Garnett Timothy John

Director

—

67,581

0.1593%

$769.07K

+56.3%

Walker Maria C

Director

—

62,703

0.1478%

$713.56K

+19.5%

Pavlov George

Director

—

28,932

0.0682%

$329.25K

—

Cox Troy

Director

—

23,484

0.0553%

$267.25K

—

Babler Martin

Director

—

7,864

0.0185%

$89.49K

—

Luneborg Nanna Liebach

Director

—

3,932

0.0093%

$44.75K

—

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 7

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 66,227

History held since 28 Oct 2025